Nabriva Therapeutics plc Financing Cash Flow
Nabriva Therapeutics plc reported Financing Cash Flow of -$4.85 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-10-19
- Nabriva Therapeutics plc net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $0.00.
- Nabriva Therapeutics plc net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was -$4.85M, a 321.15% decline year-over-year.
- Nabriva Therapeutics plc net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was -$659.00K, a 130.82% decline year-over-year.
- Nabriva Therapeutics plc net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $1.11M, a 72.79% decline year-over-year.
- Nabriva Therapeutics plc net cash provided by (used in) financing activities for fiscal 2022 was $1.85M, a 97.21% decline from fiscal 2021.
- Nabriva Therapeutics plc net cash provided by (used in) financing activities for fiscal 2021 was $66.37M, a 146.49% increase from fiscal 2020.
- Nabriva Therapeutics plc net cash provided by (used in) financing activities for fiscal 2020 was $26.92M, a 51.99% decline from fiscal 2019.
- Nabriva Therapeutics plc net cash provided by (used in) financing activities for fiscal 2019 was $56.08M, a 39.65% decline from fiscal 2018.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-19 | -$4.85M 10-Q · filed 2023-10-19 | -$5.51M derived: sum of 3 quarters · filed 2023-10-19 | -$4.40M derived: sum of 4 quarters · filed 2023-10-19 |
| 2023-03-31 | -$4.85M 10-Q · filed 2023-05-22 | -$5.51M derived: sum of 2 quarters · filed 2023-05-22 | -$4.40M derived: sum of 3 quarters · filed 2023-05-22 | -$5.20M derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-12-31 | -$659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $449.00K derived: sum of 2 quarters · filed 2023-04-17 | -$343.00K derived: sum of 3 quarters · filed 2023-10-19 | $1.85M 10-K · filed 2023-04-17 |
| 2022-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $316.00K derived: sum of 2 quarters · filed 2023-10-19 | $2.51M 10-Q · filed 2022-11-10 | $4.65M derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-06-30 | -$792.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-19 | $1.40M 10-Q · filed 2023-10-19 | $3.54M derived: sum of 3 quarters · filed 2023-10-19 | $7.61M derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-03-31 | $2.19M 10-Q · filed 2023-05-22 | $4.33M derived: sum of 2 quarters · filed 2023-05-22 | $8.40M derived: sum of 3 quarters · filed 2023-05-22 | $33.63M derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $6.21M derived: sum of 2 quarters · filed 2023-04-17 | $31.44M derived: sum of 3 quarters · filed 2023-04-17 | $66.37M 10-K · filed 2023-04-17 |
| 2021-09-30 | $4.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $29.30M derived: sum of 2 quarters · filed 2022-11-10 | $64.23M 10-Q · filed 2022-11-10 | $78.25M derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-06-30 | $25.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $60.16M 10-Q · filed 2022-08-03 | $74.18M derived: sum of 3 quarters · filed 2023-04-17 | $77.91M derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-03-31 | $34.93M 10-Q · filed 2022-05-05 | $48.95M derived: sum of 2 quarters · filed 2023-04-17 | $52.69M derived: sum of 3 quarters · filed 2023-04-17 | $92.07M derived: sum of 4 quarters · filed 2023-04-17 |
| 2020-12-31 | $14.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $17.76M derived: sum of 2 quarters · filed 2023-04-17 | $57.14M derived: sum of 3 quarters · filed 2023-04-17 | $26.92M 10-K · filed 2023-04-17 |
| 2020-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $43.12M derived: sum of 2 quarters · filed 2021-11-09 | $12.90M 10-Q · filed 2021-11-09 | $36.30M derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-06-30 | $39.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $9.17M 10-Q · filed 2021-08-05 | $32.56M derived: sum of 3 quarters · filed 2022-03-29 | $51.81M derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-03-31 | -$30.22M 10-Q · filed 2021-05-06 | -$6.82M derived: sum of 2 quarters · filed 2022-03-29 | $12.43M derived: sum of 3 quarters · filed 2022-03-29 | $16.18M derived: sum of 4 quarters · filed 2022-03-29 |
| 2019-12-31 | $23.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $42.65M derived: sum of 2 quarters · filed 2022-03-29 | $46.40M derived: sum of 3 quarters · filed 2022-03-29 | $56.08M 10-K · filed 2022-03-29 |
| 2019-09-30 | $19.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $23.00M derived: sum of 2 quarters · filed 2020-11-05 | $32.68M 10-Q · filed 2020-11-05 | $57.01M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $13.43M 10-Q · filed 2020-08-06 | $37.76M derived: sum of 3 quarters · filed 2021-03-11 | $84.13M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $9.68M 10-Q · filed 2020-05-11 | $34.01M derived: sum of 2 quarters · filed 2021-03-11 | $80.38M derived: sum of 3 quarters · filed 2021-03-11 | $83.54M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $24.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $70.70M derived: sum of 2 quarters · filed 2021-03-11 | $73.86M derived: sum of 3 quarters · filed 2021-03-11 | $92.92M 10-K · filed 2021-03-11 |
| 2018-09-30 | $46.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $49.54M derived: sum of 2 quarters · filed 2019-11-12 | $68.60M 10-Q · filed 2019-11-12 | $66.89M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $22.22M 10-Q · filed 2019-08-08 | $20.51M derived: sum of 3 quarters · filed 2020-03-12 | $95.68M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $19.06M 10-Q · filed 2019-05-10 | $17.35M derived: sum of 2 quarters · filed 2020-03-12 | $92.52M derived: sum of 3 quarters · filed 2020-03-12 | $92.45M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $73.46M derived: sum of 2 quarters · filed 2020-03-12 | $73.39M derived: sum of 3 quarters · filed 2020-03-12 | $72.22M 10-K · filed 2020-03-12 |
| 2017-09-30 | $75.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $75.10M derived: sum of 2 quarters · filed 2018-11-06 | $73.93M 10-Q · filed 2018-11-06 | $95.99M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.24M 10-Q · filed 2018-08-09 | $20.81M derived: sum of 3 quarters · filed 2019-03-12 | $20.82M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | -$1.17M 10-Q · filed 2018-05-08 | $20.89M derived: sum of 2 quarters · filed 2019-03-12 | $20.89M derived: sum of 3 quarters · filed 2019-03-12 | |
| 2016-12-31 | $22.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $22.06M derived: sum of 2 quarters · filed 2019-03-12 | $22.30M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $243.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $237.00K 10-Q · filed 2017-08-07 | |||
| 2015-12-31 | $133.02M 10-K · filed 2018-03-16 |